SEC Form 4 · accession 0001453814-15-000004

Medidata Solutions, Inc. · MDSO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Officer — Chief Financial Officer

Period of report

Feb 9, 2015

Accepted (ET)

Feb 11, 2015 · 6:13 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001453814

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 9, 2015	M	2,000	$12.08	A	149,018	D
Common Stock	Feb 9, 2015	M	25,526	$8.22	A	174,544	D
Common Stock	Feb 9, 2015	M	10,474	$13.98	A	185,018	D
Common Stock^F1	Feb 9, 2015	S	38,000	$44.2405	D	147,018	D
Common Stock^F2	Feb 10, 2015	F	1,349	$45.38	D	145,669	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F3	$12.08	Feb 9, 2015	M	2,000	D	—	Jan 10, 2018	Common Stock	2,000	3,000	D
Stock Option (right to buy)^F4	$8.22	Feb 9, 2015	M	25,526	D	—	Oct 1, 2021	Common Stock	25,526	20,372	D
Stock Option (right to buy)^F4	$13.98	Feb 9, 2015	M	10,474	D	—	May 16, 2022	Common Stock	10,474	0	D

F1Such transaction was executed in multiple trades at prices ranging from $44.15 to $44.63. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2Shares withheld by Medidata to satisfy the tax withholding obligation in connection with the vesting of previously awarded restricted stock.
F3These options are fully vested and exercisable.
F4These options vest in 48 equal monthly installments commencing one month after the grant date, subject to continued employment.